• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/26/21 5:15:27 PM ET
    $MAAC
    Business Services
    Finance
    Get the next $MAAC alert in real time by email
    SC 13G 1 efc21-208_sc13g.htm
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)*
     
    Montes Archimedes Acquisition Corp.
    (Name of Issuer)
     
    Class A Common Stock
    (Title of Class of Securities)
     
    612657106
    (CUSIP Number)
     
    18 February 2021
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [_]  Rule 13d-1(b)

    [x]  Rule 13d-1(c)

    [_]  Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.



    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




    Continued on the following pages
    Page 1 of 9 Pages
    Exhibit Index: Page 7

    SCHEDULE 13G
     
    CUSIP No. 612657106

    1
    Names of Reporting Persons
    BlueCrest Capital Management Limited
    2
    Check the appropriate box if a member of a Group (see instructions)
    (a)  [ ]
    (b)  [ ]
    3
    Sec Use Only
     
    4
    Citizenship or Place of Organization
    Jersey, Channel Islands
    Number of Shares Beneficially Owned by Each Reporting Person With:
     
    5
    Sole Voting Power
    0
    6
    Shared Voting Power
    3,000,000
    7
    Sole Dispositive Power
    0
    8
    Shared Dispositive Power
    3,000,000
    9
    Aggregate Amount Beneficially Owned by Each Reporting Person
    3,000,000
    10
    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
    [ ]
    11
    Percent of class represented by amount in row (9)
    7.3%
    12
    Type of Reporting Person (See Instructions)
    OO

    Page 2 of 9 Pages


    SCHEDULE 13G
     
    CUSIP No. 612657106

    1
    Names of Reporting Persons
    Michael Platt
    2
    Check the appropriate box if a member of a Group (see instructions)
    (a)  [ ]
    (b)  [ ]
    3
    Sec Use Only
     
    4
    Citizenship or Place of Organization
    United Kingdom
    Number of Shares Beneficially Owned by Each Reporting Person With:
     
    5
    Sole Voting Power
    0
    6
    Shared Voting Power
    3,000,000
    7
    Sole Dispositive Power
    0
    8
    Shared Dispositive Power
    3,000,000
    9
    Aggregate Amount Beneficially Owned by Each Reporting Person
    3,000,000
    10
    Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
    [ ]
    11
    Percent of class represented by amount in row (9)
    7.3%
    12
    Type of Reporting Person (See Instructions)
    IN, HC
     
    Page 3 of 9 Pages


     
    Item 1.
     
    (a)
    Name of Issuer: Montes Archimedes Acquisition Corp.
     
    (b)
    Address of Issuer’s Principal Executive Offices:

    724 Oak Grove Suite 130
    Menlo Park, CA 94025
    United States

    Item 2.
     
    (a)
    Name of Person Filing:
     
    This statement is filed by:
     

    i.
    BlueCrest Capital Management Limited (the “Investment Manager”), which serves as investment manager to Millais Limited, a Cayman Islands exempted company (the “Fund”); and
     
     
    ii.
    Michael Platt (“Mr. Platt”), who serves as principal, director, and control person of the Investment Manager,

    with respect to the Common Shares (as defined herein) held for the account of the Fund. Millais USA LLC acts as sub-investment manager of the Fund, and reports to the Investment Manager.
     
    The Investment Manager and Mr. Platt are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.
     
    (b)
    Address of Principal Business Office or, if None, Residence:

    The address of the business office of the Investment Manager and Mr. Platt is:

    Ground Floor
    Harbour Reach, La Rue de Carteret
    St Helier
    Jersey
    Channel Islands
    JE2 4HR
     
    (c)
    Citizenship: The Investment Manager is a company organized under the laws of Jersey, Channel Islands, operating solely out of Jersey, Channel Islands. Mr. Platt is a citizen of the United Kingdom.
     
    (d)
    Title and Class of Securities: Class A Common Stock (the “Common Shares”)
     
    (e)
    CUSIP No.: 612657106
     
    Item 3.
    If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: N/A
     
     

    Page 4 of 9 Pages

    Item 4.
    Ownership
     
     
    (a), (b)
    As of February 18, 2021, each of the Investment Manager and Mr. Platt may be deemed the beneficial owner of 500,000 Common Shares and 2,500,000 Common Shares underlying units held for the account of the Fund. This amount excludes warrants to purchase Shares (“Warrants”) underlying units of the Issuer held by the Reporting Persons, because the Reporting Persons do not have the right to acquire the Shares underlying the Warrants within 60 days. This amount equates to approximately 7.3% of the Common Shares outstanding. (The percentages used in this Schedule 13G are based upon 41,071,723 Common Shares reported to be outstanding in the Company’s Form 10-Q filed on November 19, 2020).
     
    (c)
    Number of shares as to which such person has: The Investment Manager and Mr. Platt share the power to vote or direct the vote, and share the power to dispose or direct the disposition of the 3,000,000 Common Shares reported herein.
     
     
    (i)
    Sole power to vote or to direct the vote: 0
     
     
    (ii)
    Shared power to vote or to direct the vote: 3,000,000
     
     
    (iii)
    Sole power to dispose or to direct the disposition of: 0
     
     
    (iv)
    Shared power to dispose or to direct the disposition of: 3,000,000
     
    Item 5.
    Ownership of Five Percent or Less of a Class. N/A
     
    Item 6.
    Ownership of more than Five Percent on Behalf of Another Person. See disclosure in Items 2 and 4 hereof. The Fund is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Shares covered by the Statement that may be deemed to be beneficially owned by the Reporting Persons.
     
    Item 7.
    Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. See disclosure in Item 2 hereof.
     
    Item 8.
    Identification and classification of members of the group. N/A
     
    Item 9.
    Notice of Dissolution of Group. N/A
     
    Item 10.
    Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
     
     
    Page 5 of 9 Pages

     
    SIGNATURE
     
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
     
    Dated:  February 26, 2021

    BLUECREST CAPITAL MANAGEMENT LIMITED
     
     
    By:
    /s/ Michael Bell
    Michael Bell
    Authorised Signatory

    MICHAEL PLATT

    By:
    /s/ Steven Pariente
    Steven Pariente
    As attorney-in-fact for Michael Platt

     
     
    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative.  If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference.  The name and any title of each person who signs the statement shall be typed or printed beneath his signature.
     
     

     
    Page 6 of 9 Pages

     
    EXHIBIT INDEX
     
     
    Ex.
     
    Page No.
    1
    Joint Filing Agreement
    8
    2
    Power of Attorney
    9
     

     
     

     
     

     
     

     
     

     
     

    Page 7 of 9 Pages


     
    EXHIBIT 1
     
     
    JOINT FILING AGREEMENT
     
     
    PURSUANT TO RULE 13d-1(k)
     
     
    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
     
     

     
     
    Date: February 26, 2021
     
     

    BLUECREST CAPITAL MANAGEMENT LIMITED
     
     
    By:
    /s/ Michael Bell
    Michael Bell
    Authorised Signatory

    MICHAEL PLATT

    By:
    /s/ Steven Pariente
    Steven Pariente
    As attorney-in-fact for Michael Platt

     
     

     
     
    Page 8 of 9 Pages


     
    EXHIBIT 2
     
     
    POWER OF ATTORNEY
     
     

     
     
    KNOW ALL MEN BY THESE PRESENT, that I, Michael Edward Platt, hereby make, constitute and appoint Steven Pariente, acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as principal of, or in other capacities with, BlueCrest Capital Management Limited, a company organized under the laws of Jersey, Channel Islands, and operating solely out of Jersey, Channel Islands, and each of the affiliates or entities advised or controlled by me or BlueCrest Capital Management Limited, all documents, certificates, instruments, statements, filings and agreements (“documents”) to be filed with or delivered to the United States Securities and Exchange Commission (the “SEC”) pursuant to the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (the “Act”), and the rules and regulations promulgated thereunder, including, without limitation: (1) all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act, including, without limitation: (a) any acquisition statements on Schedule 13D or Schedule 13G and any amendments thereto, (b) any joint filing agreements pursuant to Rule 13d-1(k), and (c) any initial statements of, or statements of changes in, beneficial ownership of securities on Form 3, Form 4 or Form 5; (2) any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act; (3) any information statements on Form 13H required to be filed with the SEC pursuant to Section 13(h) of the Act.
     
     
    All past acts of this attorney-in-fact in furtherance of the foregoing are hereby ratified and confirmed.
     
     
    This Power of Attorney shall remain in effect until revoked, in writing, by the undersigned.
     
     
    IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney, this 10th day of January 2019.
     
     
     
     
     
     /s/ Michael Platt
     
     
     
     Michael Platt
     


     
     

    Page 9 of 9 Pages
    Get the next $MAAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MAAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MAAC
    SEC Filings

    View All

    SEC Form 15-12B filed by Montes Archimedes Acquisition Corp.

    15-12B - Montes Archimedes Acquisition Corp (0001819263) (Filer)

    10/12/21 8:30:50 AM ET
    $MAAC
    Business Services
    Finance

    SEC Form 25-NSE filed by Montes Archimedes Acquisition Corp.

    25-NSE - Montes Archimedes Acquisition Corp (0001819263) (Subject)

    9/30/21 4:11:17 PM ET
    $MAAC
    Business Services
    Finance

    Montes Archimedes Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events

    8-K - Montes Archimedes Acquisition Corp (0001819263) (Filer)

    9/29/21 7:58:17 AM ET
    $MAAC
    Business Services
    Finance

    $MAAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Patient Square Capital Llc

    4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)

    10/4/21 5:20:05 PM ET
    $MAAC
    Business Services
    Finance

    SEC Form 4 filed by Walker Maria C

    4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)

    10/4/21 5:13:55 PM ET
    $MAAC
    Business Services
    Finance

    SEC Form 4 filed by Oesterle Stephen N.

    4 - Montes Archimedes Acquisition Corp (0001819263) (Issuer)

    10/4/21 5:13:42 PM ET
    $MAAC
    Business Services
    Finance

    $MAAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing

    Roivant will begin trading on Nasdaq under the ticker "ROIV" later todayR&D Day presentations from September 28th highlighting Roivant's pipeline and discovery platform available on Roivant's investor page BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Roivant Sciences, a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it has closed its business combination with Montes Archimedes Acquisition Corp. (NASDAQ:MAAC), a special purpose acquisition company, as well as a concurrent PIPE financing. Outstanding shares and warrants of MAAC have been exchanged for newly issued Roivant shares and w

    10/1/21 8:00:00 AM ET
    $MAAC
    Business Services
    Finance

    Roivant Provides Corporate Updates

    NEW YORK and BASEL, Switzerland, June 9, 2021 /PRNewswire/ -- Roivant Sciences today announced that Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data exchange, have signed a definitive merger agreement. The combined entity, to be named Datavant, will be the nation's largest health data ecosystem, enabling patients, providers, payers, health data analytics companies, patient-facing applications, government agencies, and life science companies to securely exchange their patient-level data. The combined company will have an enterprise value of $7 billion. The merger is subject to typical regulatory approvals and is

    6/9/21 7:40:00 AM ET
    $MAAC
    Business Services
    Finance

    Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology

    NEW YORK, MENLO PARK, Calif., LONDON, and BASEL, Switzerland, May 3, 2021 /PRNewswire/ -- Roivant Sciences, a biopharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. (NASDAQ:MAAC), a special purpose acquisition company sponsored by Patient Square Capital, today announced that they have entered into a definitive business combination agreement. Upon closing of the transaction, outstanding shares and warrants of MAAC will be exchanged for newly issued shares and warrants of Roivant Sciences, which is expected to be listed on Nasdaq under the new ticker symbol "ROIV." The transaction is expected to deliver up to $611 million of gross proceeds to fund discover

    5/3/21 7:00:00 AM ET
    $MAAC
    Business Services
    Finance

    $MAAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Montes Archimedes Acquisition Corp. (Amendment)

    SC 13G/A - Montes Archimedes Acquisition Corp (0001819263) (Subject)

    10/12/21 11:51:38 AM ET
    $MAAC
    Business Services
    Finance

    SEC Form SC 13G filed by Montes Archimedes Acquisition Corp.

    SC 13G - Montes Archimedes Acquisition Corp (0001819263) (Subject)

    9/27/21 5:14:37 PM ET
    $MAAC
    Business Services
    Finance

    SEC Form SC 13G filed

    SC 13G - Montes Archimedes Acquisition Corp (0001819263) (Subject)

    2/26/21 5:15:27 PM ET
    $MAAC
    Business Services
    Finance